Theaterstrasse 8, 
8001 Zurich 

  Tel: +41 44 295 30 45
  Fax +41 44 295 30 46

Publikationen

Solitary tumour-like mass lesions of the central nervous system: Primary angiitis of the CNS and inflammatory pseudotumour.
Killeen T, Jucker D, Went P, Muthurajah V, Woon K, Cesnulis E, Czaplinski A.
Clin Neurol Neurosurg. 2015 Aug;135:34-7.

A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Ramseier SP, Roth S, Czaplinski A.
BMC Pharmacol Toxicol. 2015 Apr 1;16:7.

Extradural spinal cavernous malformation: a rare but important mimic.
Killeen T, Czaplinski A, Cesnulis E.
Br J Neurosurg. 2014 Jun;28(3):340-6.

Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS).
Preiningerova JL, Baumhackl U, Csepany T, Czaplinski A, Deisenhammer F, Derfuss Tet al.
CNS Neurosci Ther. 2013 May;19(5):302-6.

Extradural spinal cavernous malformation: a rare but important mimic.
Killeen T, Czaplinski A, Cesnulis E
British J Neurosurg. 2013 Sep 27.

Multiple Sklerose: wie Sie Mimicks auf die Spuren kommen
Czaplinski A
Info Neurologie und Psychiatrie 2013, Vol 11, Nr 6.

Radikulopathie diagnostizieren und therapieren
Czaplinski A
Info Neurologie und Psychiatrie 2013, Vol 11, Nr 2.

Evaluation der Polyneuropathien und Therapieoptionen bei häufigen Formen
Czaplinski A
Swiss Medical Forum 2013. 13 (24): 476-482. A

Warum ein Karpaltunnelsyndrom keine Banalität ist.
Czaplinski A
Leading opinions in Neurologie und Psychiatrie 2013, Nr 12, Seite 33.

ALS patients with SOD1 mutations in Switzerland show very diverse phenotypes and extremely long survival.
Weber M., Neuwirth C, Thierbach J, Schweikert K, Czaplinski A, Petersen J, Jung HH, Birve A, Marklund SL, Andersen PM
J Neurol Neurosurg Psychiatry. 2012;83(3):351-3.

Inter-rater reliability of the Full Outline of UnResponsiveness score and the Glasgow Coma Scale in critically ill patients: a prospective observational study.
Fischer M, Rüegg S, Czaplinski A, Strohmeier M, Lehmann A, Tschan F, Hunziker PR, Marsch SC.
Crit Care. 2010;14(2):R64

Posterior reversible encephalopathy as the initial manifestation of a Guillain-Barré syndrome.
Sutter R, Mengiardi B, Lyrer P, Czaplinski A.
Neuromuscul Disord. 2009;19(10):709-10.

Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.
Kuhle J, Lindberg RL, Regeniter A, Mehling M, Steck AJ, Kappos L, Czaplinski A.
Eur J Neurol. 2009;16(6):771-4.

Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.
Steck AJ, Czaplinski A, Renaud S.
Neurotherapeutics. 2008;5(4):528-34.

Reconsidering clinical outcomes in Multiple Sclerosis: relapses, impairment, disability and beyond.
D'Souza M, Kappos L, Czaplinski A.
J Neurol Sci, 2008;274(1-2):76-9

Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.
Steck AJ, Czaplinski A, Renaud S.
Neurotherapeutics, 2008;5:528-34

ALSFRS and appel ALS scores: Discordance with disease progression.
Voustianiouk A, Seidel G, Panchal J, Czaplinski A, Yen A, Appel SH, Lange DJ.
Muscle Nerve, 2008;37(5):668-72

Isolierte Nervenausfälle, Entrapment syndrome.
Czaplinski A.
In: Internistische Notfälle, 2008. Schoenenberger et al. Thieme Verlag

Nicht-traumatische Querschnittslähmungen.
Czaplinski A.
Info Neurologie Psychiatrie, 2007; 5: 15-19

Cranial and peripheral neuropathy due to leptomeningeal infiltration in patient with Waldenstrom's macroglobulinemia.
R. Sutter, C. Arber, A. Tichelli, AJ. Steck, A. Czaplinski
J Neurology,2007;254:1122-3.

Primary lateral sclerosis presenting with isolated progressive pseudobulbar syndrome.
A. Becker, M. Hardmeier, AJ. Steck, A. Czaplinski
European J Neurology, 2007;14:e3

Application of the Database Controls in Experimental Trials for ALS.
Czaplinski, LJ. Haverkamp, AA. Yen, EP Simpson, EC. Lai,  SH Appel
Neurology, 2006;67:1827-32.

Slower disease progression and prolonged survival in contemporary ALS patients: is the natural history of ALS changing?
A. Czaplinski, AA. Yen, EP. Simpson, SH. Appel
Archives of Neurology, 2006;63:1139-1143

Percent-predicted forced vital capacity (FVC) at first examination is a meaningful indicator of disease progression and survival in an ALS clinic population.
A. Czaplinski, AA. Yen, SH. Appel
Journal of Neurology, Neurosurgery and Psychiatry, 2006;77:390-392

Amyotrophic Lateral Sclerosis: Can We Predict the Course of Disease?
A. Czaplinski, SH. Appel
Swiss Archives of Neurology and Psychiatry;2006;157:317-322

Symptomatische Therapie der Amyotrophischen Lateralsklerose.
A.Czaplinski, K. Schweikert, W.Strobel, AJ. Steck, M. Weber
Schweiz Rundsch Med Prax. 2006;95:263-271

Amyotrophic lateral sclerosis: early predictors of prolonged survival.
A. Czaplinski, AA. Yen, SH. Appel
Journal of Neurology, 2006;253(11):1428-36

Predictability of disease progression in amyotrophic lateral sclerosis.
A. Czaplinski, AA. Yen, EP. Simpson, SH. Appel
Muscle & Nerve, 2006;34:702-8

IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy.
R. Lombardi, B. Erne, G. Lauria, D. Pareyson, M. Borgna, M. Morbin, A. Arnold,
A.Czaplinski, P. Fuhr, N. Schaeren-Wiemers, A.J. Steck
Ann Neurol. 2005; 57:180-7

Immune mediated neuropathies--an update on therapeutic strategies.
A. Czaplinski, A.J. Steck
J Neurol. 2004;251:127-37

Flail arm syndrome: a clinical variant of amyotrophic lateral sclerosis.
A. Czaplinski, A.J. Steck, P.M. Andersen, M. Weber
Eur J Neurol. 2004;1:567-8

Einsatz von i.v. Immunoglobulinen in der Neurologie. Evidenzbasierter Konsens.
M.Stangel, R. Gold (A. Czaplinski unter den Mitglieder der IVIg Konsensusgruppe).
Nervenarzt 2004;75:801-815

Ice pack test for Myasthenia gravis. A simple, noninvasive and safe diagnostic method.
Czaplinski, A.J. Steck, P. Fuhr
J Neurol. 2003;250:883-4

Respiratory failure due to bilateral diaphragma palsy as first manifestation of ALS.
A.  Czaplinski, W. Strobel, C. Gobbi, A. J. Steck, P. Fuhr, D. Leppert
Med Sci Monit. 2003;9:34-6

Inclusion Body Myositis (IBM). A review.
A. Czaplinski, S. Renaud, P. Fuhr.
Schweiz Rundsch Med Prax. 2003;92:649-54

Actual aspects of myasthenia gravis treatment
A. Czaplinski, A. J.  Radziwill, A. J.  Steck.
Pol Merk Lek 2003;14:134-140

Diagnostic aspects of botulism. The diagnostic value of repetitive stimulation in the diagnosis of botulism.
A. Czaplinski, A.J. Radziwill, P. Graber, P. Fuhr, A.J. Steck
Akt Neurol 2002;29:76-82

Tic disorders: A review.
A. Czaplinski, A.J. Steck, P. Fuhr
Polish Neurology and Neurosurgery 2002;36:493-504

Antibody testing in peripheral neuropathies - a critical approach
A. Czaplinski, A.J.Steck
Swiss Archives of Neurology and Psychiatry 2002; 153:301-7
 
Early immunomodulatory treatment of multiple sclerosis.
A. Czaplinski
Polish Neurology and Neurosurgery 2001;3:957-60

Einschlusskörperchenmyositis. Gibt es ein typisches klinisches symptomspektrum?
A. Czaplinski
Info. Neurologie und Psychiatrie 2006; (Rezension)

Neurologie. Masuhr und Neumann. Thieme Verlag.
A. Czaplinski
Swiss Archives of Neurology and Psychiatry 2006; (Rezension)

NeurozentrumBellevue
Theaterstrasse 8, 8001 Zurich

Tel: +41 44 295 30 45
Fax +41 44 295 30 46

Design und Implementierung: extranet